{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:57:09Z","timestamp":1790963829718,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473093"],"award-info":[{"award-number":["82473093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404024"],"award-info":[{"award-number":["82404024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite advancements in therapeutic strategies, metastatic prostate cancer (mPCa) remains challenging to treat, with limited clinical efficacy and poor prognosis. Anoikis resistance in tumor cells is crucial for their survival in the vascular system and plays a key role in metastasis. Therefore, investigating the molecular mechanisms of metastasis and anoikis resistance is essential for identifying novel therapeutic targets and strategies. In this study, we found that YEATS domain-containing 2 (YEATS2) plays a critical role in promoting PCa metastasis by suppressing anoikis. We observed that YEATS2 expression was elevated in mPCa and associated with poor clinical outcomes. Knockdown of YEATS2 reduced the metastatic potential of PCa cells both in vivo and in vitro, whereas its overexpression inhibited anoikis and promoted metastasis by upregulating the expression of the DNA damage repair gene RAD50. Mechanistically, YEATS2 increases chromatin accessibility at the RAD50 promoter region by recognizing H3K27ac and subsequently recruits the transcription factor NR2C2. Mirin suppressed lymph node metastasis of PCa cells in vivo. Our study demonstrated a novel function of the YEATS2\/NR2C2\/RAD50 axis in regulating DNA damage responses and anoikis resistance in PCa metastasis, highlighting an important pathway that drives metastatic progression and offering potential new strategies for treating mPCa.<\/jats:p>","DOI":"10.1038\/s41388-026-03696-x","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:52:30Z","timestamp":1771397550000},"page":"971-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["YEATS2 promotes DNA repair and induces anoikis resistance by enhancing chromatin accessibility to drive prostate cancer metastasis"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9718-7478","authenticated-orcid":false,"given":"Haoran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0032-813X","authenticated-orcid":false,"given":"Yarong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4533-1004","authenticated-orcid":false,"given":"Yukun","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8165-0834","authenticated-orcid":false,"given":"Chuxiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4414-4260","authenticated-orcid":false,"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5303-9633","authenticated-orcid":false,"given":"Yifei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"3696_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3696_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2021","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79:263\u201382.","journal-title":"Eur Urol"},{"key":"3696_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619\u201326.","journal-title":"J Cell Biol"},{"key":"3696_CR4","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1158\/2159-8290.CD-20-1690","volume":"11","author":"HF Zhang","year":"2021","unstructured":"Zhang HF, Hughes CS, Li W, He JZ, Surdez D, El-Naggar AM, et al. Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma. Cancer Discov. 2021;11:2884\u2013903.","journal-title":"Cancer Discov"},{"key":"3696_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccell.2017.07.001","volume":"32","author":"B Strilic","year":"2017","unstructured":"Strilic B, Offermanns S. Intravascular survival and extravasation of tumor cells. Cancer Cell. 2017;32:282\u201393.","journal-title":"Cancer Cell"},{"key":"3696_CR6","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s12325-021-01729-3","volume":"38","author":"L Dai","year":"2021","unstructured":"Dai L, Song ZX, Wei DP, Zhang JD, Liang JQ, Wang BB, et al. CDC20 and PTTG1 are important biomarkers and potential therapeutic targets for metastatic prostate cancer. Adv Ther. 2021;38:2973\u201389.","journal-title":"Adv Ther"},{"key":"3696_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3548","volume":"25","author":"ZW Li","year":"2023","unstructured":"Li ZW, Yu JF, Han F, Peng J, Lu Y, Ding K. Identifying potential anti-metastasis drugs for prostate cancer through integrative bioinformatics analysis and compound library screening. J Gene Med. 2023;25:e3548.","journal-title":"J Gene Med"},{"key":"3696_CR8","doi-asserted-by":"crossref","unstructured":"Merritt N, Garcia K, Rajendran D, Lin ZY, Zhang X, Mitchell KA, et al. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ\/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex. Elife. 2021;10:e62857.","DOI":"10.7554\/eLife.62857"},{"key":"3696_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113099","volume":"42","author":"G Yayli","year":"2023","unstructured":"Yayli G, Bernardini A, Mendoza Sanchez PK, Scheer E, Damilot M, Essabri K, et al. ATAC and SAGA co-activator complexes utilize co-translational assembly, but their cellular localization properties and functions are distinct. Cell Rep. 2023;42:113099.","journal-title":"Cell Rep"},{"key":"3696_CR10","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/jcp.29995","volume":"236","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Lei S, He Z, Chen T, Jiang J. YEATS2 is a target of HIF1alpha and promotes pancreatic cancer cell proliferation and migration. J Cell Physiol. 2021;236:2087\u201398.","journal-title":"J Cell Physiol"},{"key":"3696_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01173-4","volume":"8","author":"W Mi","year":"2017","unstructured":"Mi W, Guan H, Lyu J, Zhao D, Xi Y, Jiang S, et al. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer. Nat Commun. 2017;8:1088.","journal-title":"Nat Commun"},{"key":"3696_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04077-w","volume":"12","author":"D Lu","year":"2021","unstructured":"Lu D, Song Y, Yu Y, Wang D, Liu B, Chen L, et al. KAT2A-mediated AR translocation into the nucleus promotes abiraterone-resistance in castration-resistant prostate cancer. Cell Death Dis. 2021;12:787.","journal-title":"Cell Death Dis"},{"key":"3696_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13046-022-02381-7","volume":"41","author":"Y Yu","year":"2022","unstructured":"Yu Y, Song Y, Cheng L, Chen L, Liu B, Lu D, et al. CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. J Exp Clin Cancer Res. 2022;41:188.","journal-title":"J Exp Clin Cancer Res"},{"key":"3696_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03260-1","volume":"24","author":"J Sun","year":"2024","unstructured":"Sun J, Li J, Pantopoulos K, Liu Y, He Y, Kang W, et al. The clustering status of detached gastric cancer cells inhibits anoikis-induced ferroptosis to promote metastatic colonization. Cancer Cell Int. 2024;24:77.","journal-title":"Cancer Cell Int"},{"key":"3696_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06152-x","volume":"9","author":"C Chen","year":"2018","unstructured":"Chen C, He W, Huang J, Wang B, Li H, Cai Q, et al. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2-dependent macrophage recruitment. Nat Commun. 2018;9:3826.","journal-title":"Nat Commun"},{"key":"3696_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2024.02.002","volume":"42","author":"H Zheng","year":"2024","unstructured":"Zheng H, An M, Luo Y, Diao X, Zhong W, Pang M, et al. PDGFRalpha(+)ITGA11(+) fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay. Cancer Cell. 2024;42:682\u2013700.e612.","journal-title":"Cancer Cell"},{"key":"3696_CR17","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.molcel.2021.12.004","volume":"82","author":"YC Chen","year":"2022","unstructured":"Chen YC, Koutelou E, Dent SYR. Now open: evolving insights into the roles of lysine acetylation in chromatin organization and function. Mol Cell. 2022;82:716\u201327.","journal-title":"Mol Cell"},{"key":"3696_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/pharmrev.122.000612","volume":"75","author":"AM Mustafa","year":"2023","unstructured":"Mustafa AM, Kramer OH. Pharmacological modulation of the crosstalk between aberrant Janus kinase signaling and epigenetic modifiers of the histone deacetylase family to treat cancer. Pharmacol Rev. 2023;75:35\u201361.","journal-title":"Pharmacol Rev"},{"key":"3696_CR19","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6:a018713.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3696_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161:1215\u201328.","journal-title":"Cell"},{"key":"3696_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.","journal-title":"Redox Biol"},{"key":"3696_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer. 2023;22:48.","journal-title":"Mol Cancer"},{"key":"3696_CR23","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1158\/1078-0432.CCR-18-1229","volume":"24","author":"D Iglesias-Gato","year":"2018","unstructured":"Iglesias-Gato D, Thysell E, Tyanova S, Crnalic S, Santos A, Lima TS, et al. The proteome of prostate cancer bone metastasis reveals heterogeneity with prognostic implications. Clin Cancer Res. 2018;24:5433\u201344.","journal-title":"Clin Cancer Res"},{"key":"3696_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24:679\u201386.","journal-title":"Leukemia"},{"key":"3696_CR25","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41596-022-00692-9","volume":"17","author":"FC Grandi","year":"2022","unstructured":"Grandi FC, Modi H, Kampman L, Corces MR. Chromatin accessibility profiling by ATAC-seq. Nat Protoc. 2022;17:1518\u201352.","journal-title":"Nat Protoc"},{"key":"3696_CR26","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1038\/onc.2016.3","volume":"35","author":"EB Choi","year":"2016","unstructured":"Choi EB, Yang AY, Kim SC, Lee J, Choi JK, Choi C, et al. PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair. Oncogene. 2016;35:4569\u201379.","journal-title":"Oncogene"},{"key":"3696_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrc.2022.07.066","volume":"623","author":"C Tang","year":"2022","unstructured":"Tang C, Qiu S, Mou W, Xu J, Wang P. Excessive activation of HOXB13\/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance. Biochem Biophys Res Commun. 2022;623:81\u201388.","journal-title":"Biochem Biophys Res Commun"},{"key":"3696_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2023.102404","volume":"77","author":"MA Erb","year":"2023","unstructured":"Erb MA. Small-molecule tools for YEATS domain proteins. Curr Opin Chem Biol. 2023;77:102404.","journal-title":"Curr Opin Chem Biol"},{"key":"3696_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00018-009-0199-8","volume":"67","author":"Z Nagy","year":"2010","unstructured":"Nagy Z, Riss A, Fujiyama S, Krebs A, Orpinell M, Jansen P, et al. The metazoan ATAC and SAGA coactivator HAT complexes regulate different sets of inducible target genes. Cell Mol Life Sci. 2010;67:611\u201328.","journal-title":"Cell Mol Life Sci"},{"key":"3696_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/nar\/gkaa1130","volume":"49","author":"X Ren","year":"2021","unstructured":"Ren X, Zhou Y, Xue Z, Hao N, Li Y, Guo X, et al. Histone benzoylation serves as an epigenetic mark for DPF and YEATS family proteins. Nucleic Acids Res. 2021;49:114\u201326.","journal-title":"Nucleic Acids Res"},{"key":"3696_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/cr.2016.49","volume":"26","author":"D Zhao","year":"2016","unstructured":"Zhao D, Guan H, Zhao S, Mi W, Wen H, Li Y, et al. YEATS2 is a selective histone crotonylation reader. Cell Res. 2016;26:629\u201332.","journal-title":"Cell Res"},{"key":"3696_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2007.01.015","volume":"128","author":"B Li","year":"2007","unstructured":"Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell. 2007;128:707\u201319.","journal-title":"Cell"},{"key":"3696_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","volume":"550","author":"LM Lasko","year":"2017","unstructured":"Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature. 2017;550:128\u201332.","journal-title":"Nature"},{"key":"3696_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187:294\u2013311 e221.","journal-title":"Cell"},{"key":"3696_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nchembio.63","volume":"4","author":"A Dupre","year":"2008","unstructured":"Dupre A, Boyer-Chatenet L, Sattler RM, Modi AP, Lee JH, Nicolette ML, et al. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol. 2008;4:119\u201325.","journal-title":"Nat Chem Biol"},{"key":"3696_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/15384101.2024.2342714","volume":"23","author":"Q Wu","year":"2024","unstructured":"Wu Q, Zheng Q, Yuan L, Gao D, Hu Y, Jiang X, et al. Repression of YEATS2 induces cellular senescence in hepatocellular carcinoma and inhibits tumor growth. Cell Cycle. 2024;23:478\u201394.","journal-title":"Cell Cycle"},{"key":"3696_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68348-0","volume":"14","author":"N Du","year":"2024","unstructured":"Du N, Yi L, Wang J, Lei Y, Bo X, Guo F, et al. High expression of YEATS2 as a predictive factor of poor prognosis in patients with hepatocellular carcinoma. Sci Rep. 2024;14:17246.","journal-title":"Sci Rep"},{"key":"3696_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07091-w","volume":"15","author":"M Liao","year":"2024","unstructured":"Liao M, Zheng W, Wang Y, Li M, Sun X, Liu N, et al. LINC00887 promotes GCN5-dependent H3K27cr level and CRC metastasis via recruitment of YEATS2 and enhancing ETS1 expression. Cell Death Dis. 2024;15:711.","journal-title":"Cell Death Dis"},{"key":"3696_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-021-09671-4","volume":"39","author":"H Sheng","year":"2023","unstructured":"Sheng H, Zheng F, Lan T, Chen HF, Xu CY, Wang SW, et al. YEATS2 regulates the activation of TAK1\/NF-kappaB pathway and is critical for pancreatic ductal adenocarcinoma cell survival. Cell Biol Toxicol. 2023;39:1\u201316.","journal-title":"Cell Biol Toxicol"},{"key":"3696_CR40","doi-asserted-by":"crossref","unstructured":"Xie Y, Sahin M, Wakamatsu T, Inoue-Yamauchi A, Zhao W, Han S, et al. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis. JCI Insight. 2023;8:e154120.","DOI":"10.1172\/jci.insight.154120"},{"key":"3696_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106896","volume":"195","author":"S Li","year":"2023","unstructured":"Li S, Yang M, Teng S, Lin K, Wang Y, Zhang Y, et al. Chromatin accessibility dynamics in colorectal cancer liver metastasis: uncovering the liver tropism at single cell resolution. Pharmacol Res. 2023;195:106896.","journal-title":"Pharmacol Res"},{"key":"3696_CR42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41556-021-00728-4","volume":"23","author":"SE Pierce","year":"2021","unstructured":"Pierce SE, Granja JM, Corces MR, Brady JJ, Tsai MK, Pierce AB, et al. LKB1 inactivation modulates chromatin accessibility to drive metastatic progression. Nat Cell Biol. 2021;23:915\u201324.","journal-title":"Nat Cell Biol"},{"key":"3696_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42656-x","volume":"14","author":"WD Pontius","year":"2023","unstructured":"Pontius WD, Hong ES, Faber ZJ, Gray J, Peacock CD, Bayles I, et al. Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis. Nat Commun. 2023;14:7209.","journal-title":"Nat Commun"},{"key":"3696_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114036","volume":"157","author":"S Guo","year":"2023","unstructured":"Guo S, Zhu X, Huang Z, Wei C, Yu J, Zhang L, et al. Genomic instability drives tumorigenesis and metastasis and its implications for cancer therapy. Biomed Pharmacother. 2023;157:114036.","journal-title":"Biomed Pharmacother"},{"key":"3696_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13046-023-02789-9","volume":"42","author":"T Liu","year":"2023","unstructured":"Liu T, Wang H, Chen Y, Wan Z, Du Z, Shen H, et al. SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation. J Exp Clin Cancer Res. 2023;42:234.","journal-title":"J Exp Clin Cancer Res"},{"key":"3696_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04672-5","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Dong D, Xia Y, Hao L, Wang W, Zhao C. YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance. Cell Death Dis. 2022;13:230.","journal-title":"Cell Death Dis"},{"key":"3696_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203884","volume":"10","author":"W Liu","year":"2023","unstructured":"Liu W, Zheng M, Zhang R, Jiang Q, Du G, Wu Y, et al. RNF126-mediated MRE11 ubiquitination activates the DNA damage response and confers resistance of triple-negative breast cancer to radiotherapy. Adv Sci. 2023;10:e2203884.","journal-title":"Adv Sci"},{"key":"3696_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2021.05.033","volume":"516","author":"J Li","year":"2021","unstructured":"Li J, Tian L, Jing Z, Guo Z, Nan P, Liu F, et al. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis. Cancer Lett. 2021;516:13\u201327.","journal-title":"Cancer Lett"},{"key":"3696_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.onc.1210700","volume":"27","author":"A Kauffmann","year":"2008","unstructured":"Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P, et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2008;27:565\u201373.","journal-title":"Oncogene"},{"key":"3696_CR50","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7150\/thno.88057","volume":"14","author":"I Gorodetska","year":"2024","unstructured":"Gorodetska I, Offermann A, Puschel J, Lukiyanchuk V, Gaete D, Kurzyukova A, et al. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics. 2024;14:714\u201337.","journal-title":"Theranostics"},{"key":"3696_CR51","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-22-4017","volume":"83","author":"M Wei","year":"2023","unstructured":"Wei M, Huang X, Liao L, Tian Y, Zheng X. SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer. Cancer Res. 2023;83:2908\u201323.","journal-title":"Cancer Res"},{"key":"3696_CR52","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/s41416-023-02417-5","volume":"129","author":"C Gulliver","year":"2023","unstructured":"Gulliver C, Huss S, Semjonow A, Baillie GS, Hoffmann R. Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies. Br J Cancer. 2023;129:1462\u201376.","journal-title":"Br J Cancer"},{"key":"3696_CR53","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ijc.34778","volume":"154","author":"K Frei","year":"2024","unstructured":"Frei K, Schecher S, Daher T, Horner N, Richter J, Hildebrand U, et al. Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer. Int J Cancer. 2024;154:1082\u201396.","journal-title":"Int J Cancer"},{"key":"3696_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5:60.","journal-title":"Signal Transduct Target Ther"},{"key":"3696_CR55","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.molcel.2019.06.023","volume":"75","author":"Y Bai","year":"2019","unstructured":"Bai Y, Wang W, Li S, Zhan J, Li H, Zhao M, et al. C1QBP promotes homologous recombination by stabilizing MRE11 and controlling the assembly and activation of MRE11\/RAD50\/NBS1 complex. Mol Cell. 2019;75:1299\u20131314.e1296.","journal-title":"Mol Cell"},{"key":"3696_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1091496","volume":"304","author":"JH Lee","year":"2004","unstructured":"Lee JH, Paull TT. Direct activation of the ATM protein kinase by the Mre11\/Rad50\/Nbs1 complex. Science. 2004;304:93\u201396.","journal-title":"Science"},{"key":"3696_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1100-5","volume":"18","author":"L Bian","year":"2019","unstructured":"Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Mol Cancer. 2019;18:169.","journal-title":"Mol Cancer"},{"key":"3696_CR58","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1002\/jcb.29580","volume":"121","author":"WH Xu","year":"2020","unstructured":"Xu WH, Wang J, Sheng HY, Qu YY, Wang HK, Zhu Y, et al. Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancer. J Cell Biochem. 2020;121:3124\u201334.","journal-title":"J Cell Biochem"},{"key":"3696_CR59","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.1038\/s41388-020-01460-3","volume":"39","author":"J Yuan","year":"2020","unstructured":"Yuan J, Song Y, Pan W, Li Y, Xu Y, Xie M, et al. LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5. Oncogene. 2020;39:6664\u201376.","journal-title":"Oncogene"},{"key":"3696_CR60","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.2337\/db07-0359","volume":"56","author":"NC Liu","year":"2007","unstructured":"Liu NC, Lin WJ, Kim E, Collins LL, Lin HY, Yu IC, et al. Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis. Diabetes. 2007;56:2901\u20139.","journal-title":"Diabetes"},{"key":"3696_CR61","doi-asserted-by":"publisher","first-page":"46919","DOI":"10.1074\/jbc.M304088200","volume":"278","author":"E Kim","year":"2003","unstructured":"Kim E, Xie S, Yeh SD, Lee YF, Collins LL, Hu YC, et al. Disruption of TR4 orphan nuclear receptor reduces the expression of liver apolipoprotein E\/C-I\/C-II gene cluster. J Biol Chem. 2003;278:46919\u201326.","journal-title":"J Biol Chem"},{"key":"3696_CR62","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1152\/ajpendo.00701.2010","volume":"301","author":"YF Lee","year":"2011","unstructured":"Lee YF, Liu S, Liu NC, Wang RS, Chen LM, Lin WJ, et al. Premature aging with impaired oxidative stress defense in mice lacking TR4. Am J Physiol Endocrinol Metab. 2011;301:E91\u201398.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3696_CR63","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1210\/en.2008-0121","volume":"149","author":"G Li","year":"2008","unstructured":"Li G, Lee YF, Liu S, Cai Y, Xie S, Liu NC, et al. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. Endocrinology. 2008;149:3490\u20139.","journal-title":"Endocrinology"},{"key":"3696_CR64","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/carcin\/bgu052","volume":"35","author":"SJ Lin","year":"2014","unstructured":"Lin SJ, Lee SO, Lee YF, Miyamoto H, Yang DR, Li G, et al. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of the DNA damage\/repair system. Carcinogenesis. 2014;35:1399\u2013406.","journal-title":"Carcinogenesis"},{"key":"3696_CR65","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ijc.29049","volume":"136","author":"X Ding","year":"2015","unstructured":"Ding X, Yang DR, Lee SO, Chen YL, Xia L, Lin SJ, et al. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2\/CCR2 signaling. Int J Cancer. 2015;136:955\u201364.","journal-title":"Int J Cancer"},{"key":"3696_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-014-0281-1","volume":"14","author":"X Ding","year":"2015","unstructured":"Ding X, Yang DR, Xia L, Chen B, Yu S, Niu Y, et al. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1\/MMP2\/MMP9 signals. Mol Cancer. 2015;14:16.","journal-title":"Mol Cancer"},{"key":"3696_CR67","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1158\/1535-7163.MCT-14-0971","volume":"14","author":"J Zhu","year":"2015","unstructured":"Zhu J, Yang DR, Sun Y, Qiu X, Chang HC, Li G, et al. TR4 nuclear receptor alters the prostate cancer CD133+ stem\/progenitor cell invasion via modulating the EZH2-related metastasis gene expression. Mol Cancer Ther. 2015;14:1445\u201353.","journal-title":"Mol Cancer Ther"},{"key":"3696_CR68","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/cas.13461","volume":"109","author":"Y Chen","year":"2018","unstructured":"Chen Y, Lu J, Xia L, Xue D, Yu X, Shen D, et al. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma. Cancer Sci. 2018;109:384\u201394.","journal-title":"Cancer Sci"},{"key":"3696_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ijc.31289","volume":"143","author":"M Wang","year":"2018","unstructured":"Wang M, Sun Y, Xu J, Lu J, Wang K, Yang DR, et al. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p\/TR4\/HGF\/met signaling. Int J Cancer. 2018;143:100\u201312.","journal-title":"Int J Cancer"},{"key":"3696_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0287-5","volume":"9","author":"R Jin","year":"2018","unstructured":"Jin R, Lin H, Li G, Xu J, Shi L, Chang C, et al. TR(4) nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression. Cell Death Dis. 2018;9:283.","journal-title":"Cell Death Dis"},{"key":"3696_CR71","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cell.2014.09.037","volume":"159","author":"H Huang","year":"2014","unstructured":"Huang H, Sabari BR, Garcia BA, Allis CD, Zhao Y. SnapShot: histone modifications. Cell. 2014;159:458\u2013458.e451.","journal-title":"Cell"},{"key":"3696_CR72","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-biochem-072711-165700","volume":"82","author":"DJ Patel","year":"2013","unstructured":"Patel DJ, Wang Z. Readout of epigenetic modifications. Annu Rev Biochem. 2013;82:81\u2013118.","journal-title":"Annu Rev Biochem"},{"key":"3696_CR73","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1021\/acschembio.1c00945","volume":"18","author":"X Li","year":"2023","unstructured":"Li X, Liu S, Li X, Li XD. YEATS domains as novel epigenetic readers: structures, functions, and inhibitor development. ACS Chem Biol. 2023;18:994\u20131013.","journal-title":"ACS Chem Biol"},{"key":"3696_CR74","first-page":"2076","volume":"8","author":"S You","year":"2018","unstructured":"You S, Wang F, Hu Q, Li P, Zhang C, Yu Y, et al. Abnormal expression of YEATS4 associates with poor prognosis and promotes cell proliferation of hepatic carcinoma cell by regulation the TCEA1\/DDX3 axis. Am J Cancer Res. 2018;8:2076\u201387.","journal-title":"Am J Cancer Res"},{"key":"3696_CR75","first-page":"2436","volume":"8","author":"J Kiuchi","year":"2018","unstructured":"Kiuchi J, Komatsu S, Imamura T, Nishibeppu K, Shoda K, Arita T, et al. Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma. Am J Cancer Res. 2018;8:2436\u201352.","journal-title":"Am J Cancer Res"},{"key":"3696_CR76","first-page":"416","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Li L, Wu J, Qin J, Dai X, Jin T, et al. YEATS4 is associated with poor prognosis and promotes epithelial-to-mesenchymal transition and metastasis by regulating ZEB1 expression in breast cancer. Am J Cancer Res. 2021;11:416\u201340.","journal-title":"Am J Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03696-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:03:05Z","timestamp":1773403385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03696-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,3,28]]}},"alternative-id":["3696"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03696-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were conducted in accordance with the Declaration of Helsinki, and the research protocols were approved by the Research Ethics Committees of Union Hospital, Tongji Medical College, and Huazhong University of Science and Technology. Animal experiments were approved by the Institutional Review Board of the Huazhong University of Science and Technology-affiliated Union Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS"}}]}}